Cargando…
Pharmacists and Contraception in the Inpatient Setting
The choice of contraceptive method should be based on patient specific factors, patient preference, and method-specific properties. In this article, we review opportunities for an inpatient clinical pharmacist to assist in the selection and counseling of contraceptives in hospitalized patients. An i...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356798/ https://www.ncbi.nlm.nih.gov/pubmed/32397460 http://dx.doi.org/10.3390/pharmacy8020082 |
_version_ | 1783558565107073024 |
---|---|
author | Ciriello, Domenique Cieri-Hutcherson, Nicole |
author_facet | Ciriello, Domenique Cieri-Hutcherson, Nicole |
author_sort | Ciriello, Domenique |
collection | PubMed |
description | The choice of contraceptive method should be based on patient specific factors, patient preference, and method-specific properties. In this article, we review opportunities for an inpatient clinical pharmacist to assist in the selection and counseling of contraceptives in hospitalized patients. An inpatient pharmacist has the opportunity to discuss various contraceptive methods with the patient, ensuring an appropriate method is used after discharge, which is especially important after the occurrence of a contraception-related adverse effect or contraindication to certain contraceptive methods. Barriers, such as formulary restrictions, can limit inpatient initiation of contraceptive therapy while hospitalized, but pharmacists can provide education on appropriate alternatives. Inpatient clinical pharmacists can also make recommendations for contraceptive methods in special populations. It is crucial to select an appropriate therapy in patients with an underlying medical condition, such as those with active or history of breast cancer, psychiatric disorder, or thrombophilia, as inappropriate therapy can cause an increased risk of harm. Pharmacists can assist in contraceptive counseling, evaluating for drug-drug and drug-disease interactions, and recommending the most appropriate therapy in special populations. An inpatient pharmacist has the opportunity to interact with the medical team and assist in navigation of teratogenic medication use and Risk Evaluation and Mitigation Strategies. |
format | Online Article Text |
id | pubmed-7356798 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-73567982020-07-22 Pharmacists and Contraception in the Inpatient Setting Ciriello, Domenique Cieri-Hutcherson, Nicole Pharmacy (Basel) Commentary The choice of contraceptive method should be based on patient specific factors, patient preference, and method-specific properties. In this article, we review opportunities for an inpatient clinical pharmacist to assist in the selection and counseling of contraceptives in hospitalized patients. An inpatient pharmacist has the opportunity to discuss various contraceptive methods with the patient, ensuring an appropriate method is used after discharge, which is especially important after the occurrence of a contraception-related adverse effect or contraindication to certain contraceptive methods. Barriers, such as formulary restrictions, can limit inpatient initiation of contraceptive therapy while hospitalized, but pharmacists can provide education on appropriate alternatives. Inpatient clinical pharmacists can also make recommendations for contraceptive methods in special populations. It is crucial to select an appropriate therapy in patients with an underlying medical condition, such as those with active or history of breast cancer, psychiatric disorder, or thrombophilia, as inappropriate therapy can cause an increased risk of harm. Pharmacists can assist in contraceptive counseling, evaluating for drug-drug and drug-disease interactions, and recommending the most appropriate therapy in special populations. An inpatient pharmacist has the opportunity to interact with the medical team and assist in navigation of teratogenic medication use and Risk Evaluation and Mitigation Strategies. MDPI 2020-05-09 /pmc/articles/PMC7356798/ /pubmed/32397460 http://dx.doi.org/10.3390/pharmacy8020082 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Commentary Ciriello, Domenique Cieri-Hutcherson, Nicole Pharmacists and Contraception in the Inpatient Setting |
title | Pharmacists and Contraception in the Inpatient Setting |
title_full | Pharmacists and Contraception in the Inpatient Setting |
title_fullStr | Pharmacists and Contraception in the Inpatient Setting |
title_full_unstemmed | Pharmacists and Contraception in the Inpatient Setting |
title_short | Pharmacists and Contraception in the Inpatient Setting |
title_sort | pharmacists and contraception in the inpatient setting |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356798/ https://www.ncbi.nlm.nih.gov/pubmed/32397460 http://dx.doi.org/10.3390/pharmacy8020082 |
work_keys_str_mv | AT ciriellodomenique pharmacistsandcontraceptionintheinpatientsetting AT cierihutchersonnicole pharmacistsandcontraceptionintheinpatientsetting |